Atrys Health, S.A. (FRA:A2T)
Germany flag Germany · Delayed Price · Currency is EUR
2.550
+0.010 (0.39%)
At close: Dec 4, 2025

Atrys Health Company Description

Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America.

It operates through Diagnosis, Oncology, and Preventive Medicine segments. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; online medical imaging in the fields of radiology and cardiology; oncology treatment services, such as chemotherapy, immunotherapy, radiotherapy, and brachytherapy; second opinion and genetic counselling; and diagnostic reports and genetic tests.

It also provides telemedicine services, such as teleradiology, telecardiology, teleoncology, teledermatology, teleophthalmology, and teleconsultations; prevention plans for companies, which includes training plans on occupational risk prevention; Smart Data, a technological database for healthcare; and research and development services.

The company was formerly known as Althia Health, S.L. and changed its name to Atrys Health, S.A. in May 2016.

Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain.

Atrys Health, S.A.
Country Spain
Founded 2007
Industry Medical Laboratories
Employees 2,045
CEO Marian Isach

Contact Details

Address:
Príncipe de Vergara 132
Madrid, 28002
Spain
Phone 34 917 819 465
Website atryshealth.com

Stock Details

Ticker Symbol A2T
Exchange Frankfurt Stock Exchange
Fiscal Year January - December
Reporting Currency EUR
SIC Code 8071

Key Executives

Name Position
Marian Isach Chief Executive Officer
Jose Huch Ginesta Chief Financial Officer